convidecia (trade mark) recombinant novel coronavirus vaccine (adenovirus type 5 vector) solution for injection
coxeta fc tablets 60mg
coxeta fc tablets 90mg
coxeta fc tablets 120mg
durogesic 25 mcghr transdermal patch
durogesic 50 mcghr transdermal patch
durogesic 12 mcghr transdermal patch
zantac syrup 150mg/10ml